By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Expression Pathology said today that it is collaborating with research hospitals in Toronto that will use its proteomic analysis tools in studies aimed at developing an assay that could be used to identify patients that are most likely to respond to anti-epidermal growth factor receptor (EGFR) drugs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.